Management of benign prostatic hyperplasia (BPH)

被引：1
|
作者：
Jokisch J.-F. [1 ]
Herlemann A. [1 ]
Weinhold P. [1 ]
Magistro G. [1 ]
Stief C.G. [1 ]
Gratzke C. [1 ]
机构：
[1] Urologische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, München
来源：
MMW - Fortschritte der Medizin | 2017年 / 159卷 / 9期
关键词：
Benign prostatic syndrome (BPS); bladder outlet obstruction (BOO); lower urinary tract symptoms (LUTS); medical treatment / surgical treatment;
D O I：
10.1007/s15006-017-9046-2
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：58 / 64
页数：6
相关论文
共 50 条
  • [1] Combination therapy in benign prostatic hyperplasia (BPH)
    Desgrandchamps, F
    ANNALES D UROLOGIE, 2004, 38 : S24 - S28
  • [2] Male Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)
    Roehrborn, Claus G.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (01) : 87 - +
  • [3] Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH)
    Kozminski, Michael A.
    Wei, John T.
    Nelson, Jason
    Kent, David M.
    BJU INTERNATIONAL, 2015, 115 (02) : 308 - 316
  • [4] Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation
    Heiman, Joshua
    Large, Tim
    Krambeck, Amy
    THERAPEUTIC ADVANCES IN UROLOGY, 2018, 10 (12) : 431 - 436
  • [5] Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate
    Ueckert, Stefan
    Kedia, George T.
    Tsikas, Dimitrios
    Simon, Annika
    Bannowsky, Andreas
    Kuczyk, Markus A.
    WORLD JOURNAL OF UROLOGY, 2020, 38 (06) : 1423 - 1435
  • [6] Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate
    Stefan Ückert
    George T. Kedia
    Dimitrios Tsikas
    Annika Simon
    Andreas Bannowsky
    Markus A. Kuczyk
    World Journal of Urology, 2020, 38 : 1423 - 1435
  • [7] Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic hyperplasia (BPH) patients
    Shamshirgaran, Amirreza
    Taheri, Diana
    Yahyazadeh, Seyed Reza
    Baghdadabad, Leila Zareian
    Zahmatkesh, Parisa
    Yar, Ehsan Zemanati
    Alaeddini, Farshid
    Khoshchehreh, Mahdi
    Mohammadi, Abdolreza
    Tavoosian, Ali
    Aghamir, Seyed Mohammad Kazem
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2025, 14 (01) : 44 - 50
  • [8] Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update
    Winograd, Joshua
    Venishetty, Nikit
    Codelia-Anjum, Alia
    Bhojani, Naeem
    Elterman, Dean
    Zorn, Kevin C.
    Te, Alexis
    Chughtai, Bilal
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (03) : 205 - 217
  • [9] Emerging drugs for the treatment of benign prostatic hyperplasia
    Thomas, Dominique
    Chughtai, Bilal
    Kini, Mitali
    Te, Alexis
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 201 - 212
  • [10] HERBAL DRUGS IN BENIGN PROSTRATE HYPERPLASIA (BPH). A CURRENT UPDATE
    Saxena, Varsha
    Srivastava, Niraj
    Pandey, Nitin
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (02): : 580 - 586
12345